LALPATHLAB - Swing Trade Analysis with AI Signals

Last Updated Time : 05 Nov 25, 7:43 am

Swing Trade Rating: 3.8

📈 Current Price: ₹3,160

📊 RSI: 49.9 (Neutral zone)

📉 MACD: -13.9 (Bearish crossover)

📈 DMA 50 / 200: ₹3,162 / ₹3,017 (Price near 50 DMA, above 200 DMA)

📉 Volume: 1,51,062 vs 1Wk Avg 2,47,931 (Below average)

💰 Market Cap: ₹26,500 Cr

📈 Qtr Profit Growth: +13.1%

📈 FII Holding: +0.17%

📈 DII Holding: +0.60%

📌 Optimal Entry Price

🎯 Entry Range: ₹3,130–₹3,160 (Near 200 DMA and RSI base)

📤 Exit Strategy

💡 Exit if: Price approaches ₹3,300–₹3,350 or RSI crosses 65 with weakening volume.

✅ Positive

• Strong ROCE (30.6%) and ROE (24.7%) indicate efficient capital use
• EPS of ₹63.2 and consistent dividend yield (0.76%)
• Price above 200 DMA and near 50 DMA support
• Low debt-to-equity ratio (0.06) supports financial stability
• Institutional interest rising (FII +0.17%, DII +0.60%)

⚠️ Limitation

• MACD shows bearish momentum
• Volume below weekly average, indicating weak participation
• High P/E (50.1) vs industry average (43.2)
• PEG ratio of 3.79 suggests valuation concerns

📰 Company Negative News

• MACD divergence indicates short-term weakness
• Volume drop may limit upside momentum

📈 Company Positive News

• Quarterly PAT increased from ₹129 Cr to ₹146 Cr
• FII and DII holdings both increased

🏭 Industry

• Industry P/E: 43.2 (slightly lower than LALPATHLAB’s P/E)
• Diagnostics sector benefits from rising health awareness and preventive care demand

🔚 Conclusion

LALPATHLAB offers a moderately attractive swing trade setup with strong fundamentals and institutional support. Entry near ₹3,130–₹3,160 is favorable, with an exit target around ₹3,300–₹3,350. A stop-loss below ₹3,080 is recommended to manage downside risk.

I can also track MACD and RSI trends for LALPATHLAB to help you time your exit more precisely.